ACR exact-submission catalog context
ACR AI Central provides an exact-submission model card for Rapid ICH; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-08FDA-cleared profile
iSchemaView Incorporated · CT/CTA · FDA-cleared (510(k))
Authorized purpose: Notification-only triage of adult noncontrast head CT for suspected intracranial hemorrhage; results do not replace diagnostic interpretation.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Notification-only triage of adult noncontrast head CT for suspected intracranial hemorrhage; results do not replace diagnostic interpretation.
Evidence takeaway. Evidence from the reviewed source record: iSchemaView conducted a retrospective, blinded, multicenter, multinational study with RAPID ICH to evaluate performance in identifying noncontrast CT head images containing ICH findings in 336 cases. Sensitivity was 0.899, specificity was 0.943, and time to notification of suspicion/non-suspicion was 2.28 minutes.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
Packet wording: "RAPID ICH is a radiological computer aided triage and notification software indicated for use in the analysis of non-enhanced head CT images." … "RAPID ICH uses an artificial intelligence algorithm to analyze images and highlight cases with suspected ICH on a server or standalone desktop application in parallel to the ongoing standard of care image interpretation.". Read from the exact FDA decision document on 2026-11-14.
The exact indication states analysis of non-enhanced head CT images; the current CT/CTA input wording is broader than the RAPID ICH indication.
The exact module description and indication define notification and compressed-preview output and its informational-only boundary.
Packet wording: "RAPID ICH is one input to physician diagnosis for patients undergoing screening for acute hemorrhage or acute stroke." … "indicated for use in the analysis of non-enhanced head CT images. The device is intended to assist hospital networks and trained radiologists in workflow triage". Read from the exact FDA decision document on 2026-11-14.
The exact indication names hospital networks and trained radiologists as the intended workflow users.
The exact cautions state the preview, non-diagnostic, unchanged-image, full-image-review, and patient-evaluation boundaries.
The exact packet reports the 336-case study, exact sensitivity and specificity, and time-to-notification result; the prior 80% values are not retained.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
The exact packet reports the 336-case study, exact sensitivity and specificity, and time-to-notification result; the prior 80% values are not retained.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not verified: Pricing information is recorded but not verified against a resolving source.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Non-enhanced head CT images
Scope: Exact FDA submission. The exact indication states analysis of non-enhanced head CT images; the current CT/CTA input wording is broader than the RAPID ICH indication.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-19 · FDA K193087: Rapid ICH
Source context, not route validation: The exact FDA package describes RAPID acquiring DICOM-compliant image data from DICOM files, DICOM CD-R, or a network using the DICOM protocol, and RAPID ICH sending notifications to the PACS/workstation, by email, and to a mobile application. Interface versions and local compatibility require confirmation.
Scope: Exact FDA submission. Packet wording: "RAPID acquires (DICOM compliant) medical image data from the following sources: • DICOM file • DICOM CD-R • Network using DICOM protocol" … "The application is selected via DICOM encoding which is processed by the DICOM handler within the RAPID Platform.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-11-14 · FDA K193087: Rapid ICH
Source context, not route validation: The exact FDA package describes RAPID ICH as a module hosted by the RAPID Platform, which consists of RAPID Servers on the hospital LAN inside the firewall (dedicated, or virtualized on a dedicated hospital server) and an iSchemaView Server. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "the RAPID ICH module which functions as one of many image processing modules hosted by the platform." … "RAPID is a software-only device consisting of one or more RAPID Servers (dedicated or virtual and an iSchemaView Server). The RAPID Server is an image processing engine that connects to a hospital LAN, inside the Hospital Firewall.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 · FDA K193087: Rapid ICH
Source context, not route validation: Notifications for cases with suspected ICH findings, including compressed preview images meant for informational purposes only and not intended for diagnostic use beyond notification.
Scope: Exact FDA submission. The exact module description and indication define notification and compressed-preview output and its informational-only boundary.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-19 · FDA K193087: Rapid ICH
Unresolved route: Notifications for cases with suspected ICH findings, including compressed preview images meant for informational purposes only and not intended for diagnostic use beyond notification.
Scope: Exact FDA submission. The exact module description and indication define notification and compressed-preview output and its informational-only boundary.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-19 · FDA K193087: Rapid ICH
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Packet wording: "the RAPID ICH module which functions as one of many image processing modules hosted by the platform." … "RAPID is a software-only device consisting of one or more RAPID Servers (dedicated or virtual and an iSchemaView Server). The RAPID Server is an image processing engine that connects to a hospital LAN, inside the Hospital Firewall.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Packet wording: "RAPID acquires (DICOM compliant) medical image data from the following sources: • DICOM file • DICOM CD-R • Network using DICOM protocol" … "The application is selected via DICOM encoding which is processed by the DICOM handler within the RAPID Platform.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
This is a current vendor-wide statement, not an independent attestation for the exact K223396 release; site-specific architecture, retention, contractual scope and current certification evidence remain unestablished.
User qualification wording only; the summary specifies no training program or training offering for this device.
Vendor statement, not an attestation. No certificate or audit report was read; the one-pager names the RapidAI platform generally and does not scope these commitments to any specific product release; exact-release scope is not established.
ACR AI Central provides an exact-submission model card for Rapid ICH; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-08Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
The exact RAPID ICH indication and performance description specify non-enhanced/noncontrast head CT rather than the broader CT/CTA value. Controlled directory display reconciled from exact FDA wording: Non-enhanced head CT -> CT/CTA.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The refreshed discovery snapshot contains 4 PubMed and 1 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 4 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor security document, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public price or quote for the exact K193087 configuration was established in this review.
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
9 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary, deployment, integration
Scope: regulatoryIdentity, modalityContext
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: vendorWideSecurity, deployment, implementationCapabilities
Scope: postmarketSafety
Scope: security, monitoring
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Methinks Software S.L.
Authorized purpose: Methinks CTA Stroke analyzes acute-setting brain CT angiography in adults over 21 with suspected stroke for suspected large-vessel occlusion in the terminal ICA, MCA-M1, or MCA-M2 and sends PACS and/or specialist notifications in parallel to standard care; previews are informational and not diagnostic.
iSchemaView
Authorized purpose: Rapid CTA 360 analyzes adult head CTA DICOM images to flag suspected large- and medium-vessel occlusion in specified intracranial and vertebral segments and notify trained clinicians for workflow triage; notifications are informational and not diagnostic.
Methinks Software S.L.
Authorized purpose: Methinks NCCT Stroke analyzes adult non-contrast head CT to flag suspected intracranial hemorrhage and suspected large-vessel occlusion of the ICA, MCA-M1, or MCA-M2 for parallel workflow triage via PACS and/or notifications; previews are informational, not diagnostic, and a negative notification does not rule out LVO or replace CTA/standard care.
JLK, Inc.
Authorized purpose: Notification-only triage of suspected intracranial hemorrhage on non-contrast head CT
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history